Lam Research Corporation(LRCX)Earnings, Financials & Key Ratios

LRCX•NASDAQ

$275.80

$344.41B mkt cap·66.5× P/E·Price updated May 6, 2026

SectorTechnology IndustrySemiconductors Sub-IndustrySemiconductor Manufacturing Equipment

AboutLam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.Show more

Revenue$18.44B+23.7%
EBITDA$6.29B+36.0%
Net Income$5.36B+40.0%
EPS (Diluted)4.15+43.1%
Gross Margin48.7%+2.9%
EBITDA Margin34.1%+9.9%
Operating Margin32.01%+11.9%
Net Margin29.06%+13.2%
ROE58.24%+27.4%
ROIC55.66%+35.4%
Debt/Equity0.48-17.3%
Interest Coverage33.43+36.3%

Analysis→Technical→

LRCX Key Insights

Lam Research Corporation (LRCX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 55.4%
✓Strong 5Y profit CAGR of 18.9%
✓Strong Piotroski F-Score: 8/9
✓FCF machine: 29.4% free cash flow margin
✓11 consecutive years of dividend growth
✓Momentum leader: RS Rating 91 (top 9%)

✗Weaknesses

✗Expensive at 36.1x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

LRCX Price & Volume

Lam Research Corporation (LRCX) stock price & volume — 10-year historical chart

Loading chart...

LRCX Growth Metrics

Lam Research Corporation (LRCX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years13.36%

5 Years12.91%

3 Years2.29%

TTM26.53%

Profit CAGR

10 Years23.38%

5 Years18.93%

3 Years5.18%

TTM44%

EPS CAGR

10 Years27.35%

5 Years22.41%

3 Years8.27%

TTM47.63%

Return on Capital

10 Years30.78%

5 Years37.73%

3 Years35.95%

Last Year40.44%

LRCX Recent Earnings

Lam Research Corporation (LRCX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)

Q2 2026Latest

Apr 22, 2026

EPS

$1.47

Est $1.36

+8.1%

Revenue

$5.8B

Est $5.8B

+1.6%

Q1 2026

Jan 28, 2026

EPS

$1.27

Est $1.17

+8.5%

Revenue

$5.3B

Est $5.2B

+2.1%

Q4 2025

Oct 22, 2025

EPS

$1.26

Est $1.22

+3.3%

Revenue

$5.3B

Est $5.2B

+1.9%

Q3 2025

Jul 30, 2025

EPS

$1.33

Est $1.21

+9.9%

Revenue

$5.2B

Est $5.0B

+3.3%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 22, 2026	$1.47vs $1.36+8.1%	$5.8Bvs $5.8B+1.6%
Q1 2026	Jan 28, 2026	$1.27vs $1.17+8.5%	$5.3Bvs $5.2B+2.1%
Q4 2025	Oct 22, 2025	$1.26vs $1.22+3.3%	$5.3Bvs $5.2B+1.9%
Q3 2025	Jul 30, 2025	$1.33vs $1.21+9.9%	$5.2Bvs $5.0B+3.3%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
AMATApplied Materials, Inc.Direct Competitor	325.78B	410.82	47.44	4.39%	24.67%	34.28%	1.75%	0.32
KLACKLA CorporationDirect Competitor	227.69B	1732.90	57.06	23.89%	35.66%	89.07%	1.64%	1.30
ASMLASML Holding N.V.Direct Competitor	560.07B	1442.92	51.81	11.02%	29.42%	47.08%	2.23%	0.14
TERTeradyne, Inc.Direct Competitor	55.91B	357.10	102.61	13.13%	22.55%	29.72%	0.81%	0.12
ONTOOnto Innovation Inc.Direct Competitor	15.17B	305.00	109.71	1.82%	10.33%	5.19%	1.98%	0.01
ACLSAxcelis Technologies, Inc.Product Competitor	4.53B	139.70	36.76	-17.57%	14.33%	11.62%	2.36%	0.04
NVMINova Ltd.Product Competitor	15.1B	515.87	89.72	29.83%	29.44%	19.66%	1.44%	0.25
CAMTCamtek Ltd.Product Competitor	7.18B	197.20	81.49	36.1%	28.36%	21.35%		0.38

Compare LRCX vs Peers

Lam Research Corporation (LRCX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AMAT

Most directly comparable listed peer for LRCX.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare LRCX against a more recognizable public peer.

Peer Set

Compare Top 5

vs AMAT, KLAC, ASML, TER

LRCX Income Statement

Lam Research Corporation (LRCX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Sales/Revenue	8.01B	11.08B	9.65B	10.04B	14.63B	17.23B	17.43B	14.91B	18.44B	21.68B
Revenue Growth %	36.15%	38.23%	-12.85%	4.05%	45.61%	17.78%	1.16%	-14.47%	23.68%	26.53%
Cost of Goods Sold	4.41B	5.91B	5.3B	5.44B	7.82B	9.36B	9.65B	7.85B	9.46B	10.85B
COGS % of Revenue	55.03%	53.37%	54.85%	54.12%	53.47%	54.31%	55.38%	52.68%	51.3%	-
Gross Profit	3.6B▲ 0%	5.17B▲ 43.3%	4.36B▼ 15.6%	4.61B▲ 5.7%	6.81B▲ 47.7%	7.87B▲ 15.7%	7.78B▼ 1.2%	7.05B▼ 9.3%	8.98B▲ 27.3%	10.84B▲ 0%
Gross Margin %	44.97%	46.63%	45.15%	45.88%	46.53%	45.69%	44.63%	47.32%	48.7%	49.98%
Gross Profit Growth %	37.59%	43.34%	-15.62%	5.74%	47.66%	15.67%	-1.21%	-9.31%	27.31%	-
Operating Expenses	1.7B	1.95B	1.89B	1.93B	2.32B	2.49B	2.6B	2.79B	3.08B	3.41B
OpEx % of Revenue	21.23%	17.62%	19.62%	19.26%	15.88%	14.45%	14.93%	18.71%	16.7%	-
Selling, General & Admin	667.49M	762.22M	702.41M	682.48M	829.88M	885.74M	832.75M	868.25M	981.7M	1.1B
SG&A % of Revenue	8.33%	6.88%	7.28%	6.79%	5.67%	5.14%	4.78%	5.83%	5.33%	-
Research & Development	1.03B	1.19B	1.19B	1.25B	1.49B	1.6B	1.73B	1.9B	2.1B	2.31B
R&D % of Revenue	12.9%	10.74%	12.34%	12.47%	10.21%	9.31%	9.91%	12.76%	11.37%	-
Other Operating Expenses	0	0	0	0	0	0	42.15M	18.19M	0	0
Operating Income	1.9B▲ 0%	3.21B▲ 68.9%	2.46B▼ 23.3%	2.67B▲ 8.5%	4.48B▲ 67.6%	5.38B▲ 20.1%	5.17B▼ 3.8%	4.26B▼ 17.6%	5.9B▲ 38.4%	7.43B▲ 0%
Operating Margin %	23.74%	29.01%	25.53%	26.62%	30.64%	31.24%	29.7%	28.61%	32.01%	34.26%
Operating Income Growth %	77.07%	68.93%	-23.3%	8.48%	67.63%	20.08%	-3.85%	-17.6%	38.39%	-
EBITDA	2.21B	3.54B	2.77B	2.94B	4.79B	5.72B	5.52B	4.62B	6.29B	7.85B
EBITDA Margin %	27.57%	31.96%	28.74%	29.29%	32.74%	33.18%	31.66%	31.02%	34.1%	36.2%
EBITDA Growth %	61.8%	60.24%	-21.63%	6.07%	62.77%	19.34%	-3.47%	-16.2%	35.98%	38.59%
D&A (Non-Cash Add-back)	306.9M	326.39M	309.28M	268.52M	307.15M	333.74M	342.43M	359.7M	386.28M	420.33M
EBIT	1.93B	3.25B	2.56B	2.75B	4.58B	5.38B	5.3B	4.55B	5.96B	7.56B
Net Interest Income	-59.88M	-11.57M	-18.49M	-92.01M	-188.91M	-169.55M	-47.48M	66.7M	53.13M	54.1M
Interest Income	57.86M	85.81M	98.77M	85.43M	19.69M	15.21M	138.98M	251.94M	231.33M	182.49M
Interest Expense	117.73M	97.39M	117.26M	177.44M	208.6M	184.76M	186.46M	185.24M	178.2M	128.39M
Other Income/Expense	-90.46M	-61.51M	-18.16M	-98.82M	-111.22M	-188.71M	-65.65M	96.31M	57.16M	58.88M
Pretax Income	1.81B▲ 0%	3.15B▲ 74.0%	2.45B▼ 22.4%	2.57B▲ 5.2%	4.37B▲ 69.7%	5.19B▲ 18.8%	5.11B▼ 1.6%	4.36B▼ 14.7%	5.96B▲ 36.6%	7.49B▲ 0%
Pretax Margin %	22.61%	28.45%	25.34%	25.64%	29.88%	30.15%	29.32%	29.25%	32.32%	34.53%
Income Tax	113.91M	771.11M	255.14M	323.23M	462.35M	587.83M	598.28M	532.45M	599.91M	778.11M
Effective Tax Rate %	6.29%	24.47%	10.43%	12.55%	10.58%	11.32%	11.71%	12.21%	10.07%	10.39%
Net Income	1.7B▲ 0%	2.38B▲ 40.2%	2.19B▼ 7.9%	2.25B▲ 2.8%	3.91B▲ 73.6%	4.61B▲ 17.8%	4.51B▼ 2.0%	3.83B▼ 15.1%	5.36B▲ 40.0%	6.71B▲ 0%
Net Margin %	21.19%	21.49%	22.7%	22.42%	26.72%	26.73%	25.89%	25.68%	29.06%	30.94%
Net Income Growth %	85.74%	40.22%	-7.95%	2.75%	73.57%	17.83%	-2.05%	-15.14%	39.98%	44%
Net Income (Continuing)	1.7B	2.38B	2.19B	2.25B	3.91B	4.61B	4.51B	3.83B	5.36B	6.71B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.92▲ 0%	1.32▲ 43.5%	1.37▲ 3.8%	1.51▲ 10.2%	2.69▲ 78.1%	3.27▲ 21.6%	3.32▲ 1.5%	2.90▼ 12.7%	4.15▲ 43.1%	5.34▲ 0%
EPS Growth %	76.92%	43.48%	3.79%	10.22%	78.15%	21.56%	1.53%	-12.65%	43.1%	47.63%
EPS (Basic)	1.05	1.47	1.44	1.56	2.72	3.29	3.33	2.91	4.17	-
Diluted Shares Outstanding	1.84B	1.81B	1.6B	1.49B	1.45B	1.41B	1.36B	1.32B	1.29B	1.26B
Basic Shares Outstanding	1.62B	1.81B	1.52B	1.45B	1.44B	1.4B	1.35B	1.31B	1.29B	1.25B
Dividend Payout Ratio	14.34%	12.92%	30.95%	29.17%	18.6%	17.7%	20.13%	26.62%	21.45%	-

LRCX Balance Sheet

Lam Research Corporation (LRCX) balance sheet — assets, liabilities & shareholders' equity

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Total Current Assets	9.14B	9.15B	8.56B	10.85B	11.65B	12.29B	13.23B	12.88B	14.52B	13.3B
Cash & Short-Term Investments	6.04B	4.95B	5.43B	6.71B	5.73B	3.66B	5.37B	5.85B	6.39B	4.75B
Cash Only	2.38B	4.51B	3.66B	4.92B	4.42B	3.52B	5.34B	5.85B	6.39B	4.75B
Short-Term Investments	3.66B	437.34M	1.77B	1.8B	1.31B	135.73M	37.64M	0	0	0
Accounts Receivable	1.67B	2.18B	1.46B	2.1B	3.03B	4.31B	2.82B	2.52B	3.38B	4.13B
Days Sales Outstanding	76.22	71.73	55.03	76.2	75.53	91.4	59.14	61.69	66.88	61.6
Inventory	1.23B	1.88B	1.54B	1.9B	2.69B	3.97B	4.82B	4.22B	4.31B	4B
Days Inventory Outstanding	102.04	115.83	106.16	127.58	125.51	154.75	182.14	196.06	166.28	138.33
Other Current Assets	8.27M	7.69M	1.37M	0	0	0	-37.64M	298.19M	440.27M	0
Total Non-Current Assets	2.98B	3.33B	3.44B	3.71B	4.24B	4.91B	5.55B	5.86B	6.83B	7.49B
Property, Plant & Equipment	685.6M	902.55M	1.06B	1.25B	1.48B	1.65B	1.86B	2.15B	2.43B	2.85B
Fixed Asset Turnover	11.69x	12.27x	9.12x	8.06x	9.90x	10.46x	9.39x	6.92x	7.59x	8.26x
Goodwill	1.39B	1.48B	1.48B	1.48B	1.49B	1.52B	1.62B	1.63B	1.63B	0
Intangible Assets	411M	317.84M	216.95M	168.53M	132.37M	101.85M	168.45M	138.54M	182.2M	1.88B
Long-Term Investments	0	0	0	0	0	0	0	2.95M	17M	35.83M
Other Non-Current Assets	754.21M	880.58M	937.01M	806.46M	1.14B	1.65B	1.91B	1.94B	2.57B	10.87B
Total Assets	12.12B▲ 0%	12.48B▲ 2.9%	12B▼ 3.8%	14.56B▲ 21.3%	15.89B▲ 9.2%	17.2B▲ 8.2%	18.78B▲ 9.2%	18.74B▼ 0.2%	21.35B▲ 13.9%	20.79B▲ 0%
Asset Turnover	0.66x	0.89x	0.80x	0.69x	0.92x	1.00x	0.93x	0.80x	0.86x	1.02x
Asset Growth %	-1.21%	2.94%	-3.83%	21.31%	9.16%	8.2%	9.22%	-0.2%	13.87%	37.94%
Total Current Liabilities	2.95B	3.15B	2.37B	3.16B	3.53B	4.56B	4.18B	4.34B	6.57B	5.24B
Accounts Payable	464.64M	510.98M	376.56M	592.39M	829.71M	1.01B	470.7M	613.97M	854.21M	0
Days Payables Outstanding	38.45	31.55	25.96	39.78	38.72	39.45	17.8	28.54	32.97	23.09
Short-Term Debt	908.44M	610.03M	667.13M	836.11M	0	0	421K	501.32M	749.67M	4.09M
Deferred Revenue (Current)	607.67M	720.09M	381.32M	457.52M	967.33M	1.57B	1.7B	1.42B	2.57B	5.21B
Other Current Liabilities	609.34M	698.95M	464.02M	520.24M	728.96M	1.3B	1.32B	1.35B	1.48B	5.24B
Current Ratio	3.10x	2.90x	3.61x	3.43x	3.30x	2.69x	3.16x	2.97x	2.21x	2.21x
Quick Ratio	2.68x	2.31x	2.96x	2.83x	2.54x	1.82x	2.01x	2.00x	1.55x	1.55x
Cash Conversion Cycle	139.8	156.02	135.24	164	162.31	206.69	223.47	229.21	200.19	176.83
Total Non-Current Liabilities	2.19B	2.75B	4.91B	6.21B	6.34B	6.35B	6.39B	5.87B	4.92B	4.96B
Long-Term Debt	1.78B	1.81B	3.82B	4.96B	4.95B	4.96B	4.96B	4.47B	3.72B	3.73B
Capital Lease Obligations	0	0	0	11.48M	29.4M	35.99M	38.24M	12.47M	203.84M	10.5M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	400.36M	942.57M	1.08B	1.24B	1.35B	1.35B	1.38B	1.39B	991.68M	4.99B
Total Liabilities	5.14B	5.9B	7.28B	9.38B	9.86B	10.92B	10.57B	10.21B	11.48B	10.21B
Total Debt	2.69B	2.42B	4.49B	5.81B	5B	5.01B	5.01B	4.98B	4.76B	3.73B
Net Debt	315.88M	-2.1B	831.68M	895.55M	576.8M	1.48B	-325.51M	-864.52M	-1.63B	-1.02B
Debt / Equity	0.39x	0.37x	0.95x	1.12x	0.83x	0.80x	0.61x	0.58x	0.48x	0.48x
Debt / EBITDA	1.22x	0.68x	1.62x	1.97x	1.04x	0.88x	0.91x	1.08x	0.76x	0.48x
Net Debt / EBITDA	0.14x	-0.59x	0.30x	0.30x	0.12x	0.26x	-0.06x	-0.19x	-0.26x	-0.26x
Interest Coverage	16.39x	33.36x	21.86x	15.51x	21.95x	29.11x	28.40x	24.54x	33.43x	58.92x
Total Equity	6.99B▲ 0%	6.58B▼ 5.8%	4.72B▼ 28.2%	5.18B▲ 9.7%	6.03B▲ 16.3%	6.28B▲ 4.2%	8.21B▲ 30.8%	8.54B▲ 4.0%	9.86B▲ 15.5%	10.58B▲ 0%
Equity Growth %	14.51%	-5.83%	-28.22%	9.74%	16.28%	4.17%	30.77%	4.01%	15.48%	62.27%
Book Value per Share	3.80	3.64	2.95	3.48	4.15	4.46	6.04	6.47	7.64	8.42
Total Shareholders' Equity	6.99B	6.58B	4.72B	5.18B	6.03B	6.28B	8.21B	8.54B	9.86B	10.58B
Common Stock	162K	157K	144K	145K	143K	137K	133K	130K	1.27M	1.25M
Retained Earnings	6.25B	8.26B	9.93B	11.52B	14.68B	18.45B	22.03B	24.81B	28.99B	33B
Treasury Stock	-5.22B	-7.85B	-11.6B	-12.95B	-15.65B	-19.48B	-21.53B	-24.37B	-27.76B	0
Accumulated OCI	-61.7M	-57.45M	-64.03M	-94.21M	-64.13M	-109.98M	-100.71M	-130.43M	-62.42M	-121.39M
Minority Interest	0	0	0	0	0	0	0	0	0	0

LRCX Cash Flow Statement

Lam Research Corporation (LRCX) cash flow — operating, investing & free cash flow history

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Cash from Operations	2.03B	2.66B	3.18B	2.13B	3.59B	3.1B	5.18B	4.65B	6.17B	6.17B
Operating CF Margin %	25.32%	23.98%	32.9%	21.17%	24.53%	17.99%	29.72%	31.21%	33.49%	-
Operating CF Growth %	50.29%	30.87%	19.59%	-33.05%	68.74%	-13.61%	67.08%	-10.17%	32.69%	296.29%
Net Income	1.7B	2.38B	2.19B	2.25B	3.91B	4.61B	4.51B	3.83B	5.36B	6.71B
Depreciation & Amortization	306.9M	326.39M	309.28M	268.52M	307.15M	333.74M	342.43M	359.7M	386.28M	420.33M
Stock-Based Compensation	149.97M	172.22M	187.23M	189.2M	220.16M	259.06M	286.6M	293.06M	343.37M	376.68M
Deferred Taxes	104.94M	3.05M	-4.98M	-17.78M	-151.48M	-257.44M	-172.06M	-198.98M	-363.25M	-264.99M
Other Non-Cash Items	80.53M	90.6M	1.52M	6.63M	-17.39M	-44.75M	52.3M	10.24M	6.84M	-189.78M
Working Capital Changes	-310.83M	-317.19M	491.52M	-571.88M	-678.74M	-1.8B	158.74M	360.48M	441.8M	-95.83M
Change in Receivables	-411.29M	-501.63M	732.14M	-641.83M	-928.93M	-1.29B	1.45B	303.44M	-858.75M	0
Change in Inventory	-307.88M	-701.01M	281.36M	-411.61M	-792.59M	-1.35B	-961.97M	528.72M	-180.73M	0
Change in Payables	126.82M	35.66M	-131.47M	208.48M	184.62M	167.88M	-522.2M	125.94M	212M	0
Cash from Investing	-2.06B	2.75B	-1.64B	-244.08M	73.27M	612.27M	-534.56M	-370.61M	-708.09M	-907.66M
Capital Expenditures	-157.42M	-273.47M	-303.49M	-203.24M	-349.1M	-546.03M	-501.57M	-396.67M	-759.19M	-503.8M
CapEx % of Revenue	1.96%	2.47%	3.14%	2.02%	2.39%	3.17%	2.88%	2.66%	4.12%	-
Acquisitions	157.42M	-115.7M	303.49M	203.24M	349.1M	0	-119.95M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-2.87B	2.52B	-1.91B	-229.08M	-391.25M	-7.58M	86.96M	-11.71M	51.09M	-403.87M
Cash from Financing	-2.63B	-3.27B	-2.39B	-623.93M	-4.17B	-4.58B	-2.83B	-4B	-4.94B	-6.75B
Debt Issued (Net)	-1.69B	-396.09M	2B	1.31B	-862.06M	-11.89M	-23.21M	-256.1M	-507.49M	-755.56M
Equity Issued (Net)	-739.1M	-2.64B	-3.77B	-1.37B	-2.67B	-3.86B	-2.01B	-2.83B	-3.28B	-4.74B
Dividends Paid	-243.5M	-307.61M	-678.35M	-656.84M	-726.99M	-815.29M	-907.91M	-1.02B	-1.15B	-1.24B
Share Repurchases	-811.67M	-2.65B	-3.78B	-1.37B	-2.7B	-3.87B	-2.02B	-2.84B	-3.42B	-4.9B
Other Financing	38.51M	75.63M	64.75M	95.44M	95.65M	108.22M	106.35M	106.42M	143K	-14.33M
Net Change in Cash	-2.66B▲ 0%	2.13B▲ 180.2%	-855.16M▼ 140.1%	1.26B▲ 246.8%	-498.33M▼ 139.7%	-897.22M▼ 80.0%	1.81B▲ 302.2%	263.43M▼ 85.5%	556.85M▲ 111.4%	-696.15M▲ 0%
Free Cash Flow	1.87B▲ 0%	2.38B▲ 27.3%	2.87B▲ 20.6%	1.92B▼ 33.0%	3.24B▲ 68.4%	2.55B▼ 21.2%	4.68B▲ 83.2%	4.26B▼ 9.0%	5.41B▲ 27.2%	6.45B▲ 0%
FCF Margin %	23.36%	21.51%	29.76%	19.15%	22.15%	14.82%	26.84%	28.55%	29.37%	29.75%
FCF Growth %	59.31%	27.27%	20.58%	-33.05%	68.42%	-21.16%	83.16%	-9.02%	27.22%	57.62%
FCF per Share	1.02	1.32	1.80	1.29	2.23	1.82	3.44	3.22	4.20	4.20
FCF Conversion (FCF/Net Income)	1.20x	1.12x	1.45x	0.94x	0.92x	0.67x	1.15x	1.22x	1.15x	0.96x
Interest Paid	104.62M	84.4M	76.93M	171.89M	203.93M	175.53M	174.75M	173.09M	172.35M	0
Taxes Paid	28.1M	142.8M	300.27M	222.91M	518.57M	807.67M	809.75M	991.82M	972.51M	0

LRCX Key Ratios

Lam Research Corporation (LRCX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	25.94%	35.09%	38.77%	45.46%	69.73%	74.85%	62.27%	45.71%	58.24%	65.79%
Return on Invested Capital (ROIC)	22.48%	40.89%	36.83%	34.47%	53.01%	56.19%	49.61%	41.11%	55.66%	55.66%
Gross Margin	44.97%	46.63%	45.15%	45.88%	46.53%	45.69%	44.63%	47.32%	48.7%	49.98%
Net Margin	21.19%	21.49%	22.7%	22.42%	26.72%	26.73%	25.89%	25.68%	29.06%	30.94%
Debt / Equity	0.39x	0.37x	0.95x	1.12x	0.83x	0.80x	0.61x	0.58x	0.48x	0.48x
Interest Coverage	16.39x	33.36x	21.86x	15.51x	21.95x	29.11x	28.40x	24.54x	33.43x	58.92x
FCF Conversion	1.20x	1.12x	1.45x	0.94x	0.92x	0.67x	1.15x	1.22x	1.15x	0.96x
Revenue Growth	36.15%	38.23%	-12.85%	4.05%	45.61%	17.78%	1.16%	-14.47%	23.68%	26.53%

LRCX SEC Filings & Documents

Lam Research Corporation (LRCX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 22, 2026·SEC

Material company update

Feb 3, 2026·SEC

Material company update

Jan 28, 2026·SEC

10-K Annual Reports

FY 2025

Aug 11, 2025·SEC

FY 2024

Aug 29, 2024·SEC

FY 2023

Aug 15, 2023·SEC

10-Q Quarterly Reports

FY 2026

Apr 23, 2026·SEC

FY 2026

Jan 29, 2026·SEC

FY 2025

Oct 24, 2025·SEC

LRCX Frequently Asked Questions

Lam Research Corporation (LRCX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Lam Research Corporation (LRCX) reported $21.68B in revenue for fiscal year 2025. This represents a 1555% increase from $1.31B in 1996.

Lam Research Corporation (LRCX) grew revenue by 23.7% over the past year. This is strong growth.

Yes, Lam Research Corporation (LRCX) is profitable, generating $6.71B in net income for fiscal year 2025 (29.1% net margin).

Dividend & Returns

Yes, Lam Research Corporation (LRCX) pays a dividend with a yield of 0.32%. This makes it attractive for income-focused investors.

Lam Research Corporation (LRCX) has a return on equity (ROE) of 58.2%. This is excellent, indicating efficient use of shareholder capital.

Lam Research Corporation (LRCX) generated $6.45B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More LRCX

Lam Research Corporation (LRCX) financial analysis — history, returns, DCA and operating performance tools

Full LRCX Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Lam Research Corporation(LRCX)Earnings, Financials & Key Ratios

LRCX Key Insights

✓Strengths

✗Weaknesses

LRCX Price & Volume

LRCX Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

LRCX Recent Earnings

LRCX Peer Comparison

Compare LRCX vs Peers

vs AMAT

vs NVDA

Compare Top 5

LRCX Income Statement

LRCX Balance Sheet

LRCX Cash Flow Statement

LRCX Key Ratios

LRCX SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

LRCX Frequently Asked Questions

Explore More LRCX

Full LRCX Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation